|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Hypocalcemia | |||||
| Osteomalacia | |||||
| Pseudohypoparathyroidism | |||||
| Pseudopseudohypoparathyroidism | |||||
| Rickets | |||||
| 2 | More general conditions related to this trial | ||||
| Avitaminosis | |||||
| Bone Diseases | |||||
| Bone Diseases, Metabolic | |||||
| Calcium Metabolism Disorders | |||||
| Deficiency Diseases | |||||
| Genetic Diseases, Inborn | |||||
| Malnutrition | |||||
| Metabolic Diseases | |||||
| Metabolism, Inborn Errors | |||||
| Metal Metabolism, Inborn Errors | |||||
| Musculoskeletal Diseases | |||||
| Nutrition Disorders | |||||
| Vitamin D Deficiency | |||||
| Water-Electrolyte Imbalance | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Vitamin D | |||||
| 4 | More general drug interventions related to this trial | ||||
| Bone Density Conservation Agents | |||||
| Growth Substances | |||||
| Micronutrients | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Vitamins | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||